• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GNVC:US

2.5000 USD 0.1000 4.17%

As of 20:10:00 ET on 04/16/2014.

Snapshot for GenVec Inc (GNVC)

Open: 2.4100 Day's Range: 2.4000 - 2.5400 Volume: 24,127
Previous Close: 2.4000 52wk Range: 0.2499 - 4.2500 1-Yr Rtn: +110.08%

Stock Chart for GNVC

No chart data available.
  • GNVC:US 2.5000
  • 1D
  • 1M
  • 1Y
2.4000
Interactive GNVC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GNVC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7800
Est. EPS (USD) (12/2014) -0.2150
Est. PEG Ratio -
Market Cap (M USD) 43.17
Shares Outstanding (M) 17.27
30 Day Average Volume 130,926
Price/Book (mrq) 6.1802
Price/Sale (ttm) 8.7914
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GNVC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GNVC

GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. The Company specializes in the treatment of cancers, including pancreatic cancer, esophageal cancer, rectal cancer, and head and neck cancer. The Company is also involved in studies involving hearing loss and balance disorders. GenVec also develops vaccines for infectious diseases.

Douglas J SwirskyPres/CEO/CFO/Treasurer/SecyDouglas E BroughChief Scientific Officer
More Company Profile & Key Executives for GNVC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil